publication venue for Diabetes, Subclinical Atherosclerosis, and Multiple Cardiovascular Risk Factors in hard-to-reach Asymptomatic Patients 2018 Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®). 2015